MEDICAL PROCESSING TECHNOLOGIES INTERNATIONAL: what changed
MEDICAL PROCESSING TECHNOLOGIES INTERNATIONAL
Largest movements
- Cash -€38,881
down €38,881 (-34.7%), from €111,997 to €73,116
mainly Net result for the year (-€45,329) and Other debts (-€19,764)
- Stocks and contracts -€38,589
no longer reported in 2025 (was €38,589)
- Tangible fixed assets -€8,320
down €8,320 (-100%), from €8,320 to €0
of which Plant, machinery and equipment: -€5,597
- Receivables within one year -€5,489
down €5,489 (-52.8%), from €10,403 to €4,914
of which Trade receivables: -€3,200
- Deferred charges and accrued income +€2,052
up €2,052 (+26.7%), from €7,695 to €9,747
- Profit (loss) carried forward -€45,329
down €45,329 (-101%), from -€44,914 to -€90,243
- Other debts -€19,764
down €19,764 (-49.8%), from €39,652 to €19,888
- Tax, wage and social debts -€11,325
down €11,325 (-52.6%), from €21,542 to €10,217
of which Remuneration and social security: -€11,172
- Trade debts -€8,284
down €8,284 (-54.1%), from €15,309 to €7,025
- Accrued charges and deferred income -€4,524
no longer reported in 2025 (was €4,524)
- Gross operating margin -€81,968
down €81,968 (-73.2%), from €112,053 to €30,085
- Staff costs -€27,691
down €27,691 (-29.3%), from €94,498 to €66,807
- Depreciation -€7,008
no longer reported in 2025 (was €7,008)
- Other operating charges -€1,200
down €1,200 (-33.2%), from €3,619 to €2,419
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €177,003 | €87,777 | -€89,227 | -50.4% |
| Fixed assets | 21/28 | €8,320 | €0 | -€8,320 | -100% |
| Tangible fixed assets | 22/27 | €8,320 | €0 | -€8,320 | -100% |
| Land and buildings | 22 | - | €0 | = | |
| Plant, machinery and equipment | 23 | €5,597 | €0 | -€5,597 | -100% |
| Furniture and vehicles | 24 | €752 | €0 | -€752 | -100% |
| Other tangible fixed assets | 26 | €1,972 | - | -€1,972 | |
| Current assets | 29/58 | €168,684 | €87,777 | -€80,907 | -48.0% |
| Stocks and contracts in progress | 3 | €38,589 | - | -€38,589 | |
| Stocks | 30/36 | €38,589 | - | -€38,589 | |
| Amounts receivable within one year | 40/41 | €10,403 | €4,914 | -€5,489 | -52.8% |
| Trade receivables | 40 | €8,088 | €4,888 | -€3,200 | -39.6% |
| Other amounts receivable | 41 | €2,315 | €26 | -€2,289 | -98.9% |
| Cash at bank and in hand | 54/58 | €111,997 | €73,116 | -€38,881 | -34.7% |
| Deferred charges and accrued income | 490/1 | €7,695 | €9,747 | +€2,052 | +26.7% |
| Total equity and liabilities | 10/49 | €177,003 | €87,777 | -€89,227 | -50.4% |
| Equity | 10/15 | €35,975 | -€9,354 | -€45,329 | |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €18,889 | €18,889 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Tax-exempt reserves | 132 | €12,689 | €12,689 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€44,914 | -€90,243 | -€45,329 | -101% |
| Amounts payable | 17/49 | €141,028 | €97,131 | -€43,897 | -31.1% |
| Amounts payable within one year | 42/48 | €136,504 | €97,131 | -€39,373 | -28.8% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Financial debts | 43 | €60,000 | €60,000 | = | 0.0% |
| Credit institutions | 430/8 | €60,000 | €60,000 | = | 0.0% |
| Trade debts | 44 | €15,309 | €7,025 | -€8,284 | -54.1% |
| Suppliers | 440/4 | €15,309 | €7,025 | -€8,284 | -54.1% |
| Taxes, remuneration and social security | 45 | €21,542 | €10,217 | -€11,325 | -52.6% |
| Taxes | 450/3 | €10,370 | €10,217 | -€153 | -1.5% |
| Remuneration and social security | 454/9 | €11,172 | - | -€11,172 | |
| Other amounts payable | 47/48 | €39,652 | €19,888 | -€19,764 | -49.8% |
| Accrued charges and deferred income | 492/3 | €4,524 | - | -€4,524 | |
| Non-recurring operating income | 76A | €0 | €38,251 | +€38,251 | |
| Remuneration, social security and pensions | 62 | €94,498 | €66,807 | -€27,691 | -29.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,008 | - | -€7,008 | |
| Other operating charges | 640/8 | €3,619 | €2,419 | -€1,200 | -33.2% |
| Non-recurring operating charges | 66A | €0 | - | = | |
| Gross operating margin | 9900 | €112,053 | €30,085 | -€81,968 | -73.2% |
| Operating profit (loss) | 9901 | €6,928 | -€39,142 | -€46,070 | |
| Financial income | 75/76B | €87 | €554 | +€467 | +537% |
| Recurring financial income | 75 | €87 | €554 | +€467 | +537% |
| Non-recurring financial income | 76B | €0 | - | = | |
| Financial charges | 65/66B | €6,511 | €6,445 | -€66 | -1.0% |
| Recurring financial charges | 65 | €6,511 | €6,445 | -€66 | -1.0% |
| Profit (loss) for the period before taxes | 9903 | €504 | -€45,033 | -€45,537 | |
| Income taxes | 67/77 | €68 | €296 | +€229 | +337% |
| Profit (loss) for the period | 9904 | €436 | -€45,329 | -€45,766 | |
| Profit (loss) for the period to be appropriated | 9905 | €436 | -€45,329 | -€45,766 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.